Why Unite2Cure childhood cancer?

Why do we need a unified European movement? There is growing recognition across the parent/patient and professional community that promising new drugs for children and teenagers with cancer are not being developed quickly enough. Whilst there has been excellent progress…

How to change the system

Cancer remains the primary cause of death by disease of children and adolescents in Europe, yet investment in research into childhood cancers lags far behind that for adults. A few basic changes to European law, however, could transform the situation and harness the…

Sign the petition!

Call for immediate change to European Paediatric Medicine Regulation to save more lives of children and teens with cancer. A few basic changes to European Law could speed up access to newer, kinder and potentially better drugs for more children…

News

pam-kearns

It’s about acceleration

Professor Pam Kearns talks frankly about clinical trials and children’s cancer.   If you search on Facebook, you can find a picture of Pam Kearns with ‘the girl whose life she helped save.’ In the photograph, doctor and patient share…

unnamed

New drugs for childhood cancers: could biotechs end the drought?

An article in Cancerworld magazine by journalist Sophie Fessl, summarizes well the issues Unite2Cure is raising.   The chances of surviving a childhood cancer have changed very little over the past two decades. Sophie Fessl talked to parents, doctors, regulators…

Ruban-Unite2Cure.jpg1-340x330

An Update from the Unite2Cure Team

Where do we go from here? Here is an update on the state of play regarding the campaign on the Paediatric Medicines Regulation (PMR).   A Resolution to be put before the European Parliament has been drafted by members of…

Coalition4aCure

Some Facts…

It is impossible to measure the impact that childhood cancer has on it’s victims and their families by using statistics but research funding decisions are often based on numbers. Here are some facts about childhood cancer for you to consider:…

Learn More